Skip to main content

stock

BTAI · BioXcel Therapeutics, Inc.

What BioXcel Therapeutics, Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live BTAI price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on BTAI.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
31,305,499 as of 2026-08-11 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
-6054.7%
Net
-9549.9%

Returns

ROE
—
ROA
-246.1%

Health

Current ratio
0.2x
Debt/equity
—

Deep value

NCAV
-$115.56M
NCAV per share
-$3.69
Price/NCAV
Locked
NNWC
-$131.18M
NNWC per share
-$4.19
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30$182,000—Gross profit: unreported by this company.-$10.19M-$14.71M
10-Q filed 2026-08-13
2026-03-31$206,000—Gross profit: unreported by this company.-$10.22M-$12.69M
10-Q filed 2026-08-13
Assembled from more than one filing; the filing above is only the newest of them.
2025-12-31$256,000—Gross profit: unreported by this company.-$10.28M-$12.54M
10-K filed 2026-03-27
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-09-30$98,000—Gross profit: unreported by this company.-$14.23M-$30.91M
10-Q filed 2025-11-12
2025-06-30$120,000—Gross profit: unreported by this company.-$15.85M-$19.19M
10-Q filed 2026-08-13
2025-03-31$168,000—Gross profit: unreported by this company.-$10.10M-$7.25M
10-Q filed 2026-08-13
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31$366,000—Gross profit: unreported by this company.-$10.49M-$10.86M
10-K filed 2026-03-27
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2024-09-30$214,000—Gross profit: unreported by this company.-$15.29M-$13.65M
10-Q filed 2025-11-12
Assets
$28.80M
Equity
-$115.46M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$642,000-$50.46M-$69.90M-$57.62M
2024-12-31$2.27M-$67.25M-$59.60M-$72.03M
2023-12-31$1.38M-$171.78M-$179.05M-$155.03M
2022-12-31$375,000-$159.65M-$165.76M-$135.48M
2021-12-31—-$106.94M-$106.93M-$82.60M
2020-12-31—-$82.30M-$82.17M-$66.67M
2019-12-31—-$33.60M-$32.97M-$27.97M
2018-12-31—-$19.96M-$19.27M-$13.85M
2017-12-31—-$4.54M-$4.54M—

Company filings

1 offering filing in 12 months · since Wed Mar 11

events

  • New debt, Listing standard notice

    New debtListing standard notice
    Sep 18-K
  • Material agreement, Bankruptcy

    Material agreementBankruptcy
    Aug 288-K
  • Material agreement

    Material agreement
    Aug 258-K
  • Material agreement

    Material agreement
    Aug 248-K
  • Material agreement

    Material agreement
    Aug 118-K
  • Material agreement

    Material agreement
    Aug 38-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

No insider buys or sales filed in the last 90 days.

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named BTAI, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about BTAI.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about BTAI.

nakagai

Signals on BTAI come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the BTAI board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

BioXcel Therapeutics, Inc. (BTAI): SEC filings, financials and insider trades · Nakagai